# NerPharMa S.r.l. - Inspection Records

Source: https://www.keypedia.com/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391

> Inspection records and compliance data for NerPharMa S.r.l. in Nerviano, None. Access full analysis and detailed observations.

---

## Details

- Name: NerPharMa S.r.l.
- FEI Number: 3004762406
- City: Nerviano
- State: None
- Country Name: Italy
- Address Line 1: Bldgs 65 And 71 Casella Postale N. 11, Viale Luigi Pasteur 10
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [483 - NerPharMa S.r.l. - Unknown Date](https://www.keypedia.com/records/483/nerpharma-srl/e21affab-994e-45dc-be40-f9d8af6d093b) — source: FDA, date: Invalid Date
- [483 - NerPharMa S.r.l. - 2025-06-27](https://www.keypedia.com/records/483/nerpharma-srl/b59387cb-4c26-4bc0-b487-89c0c17094f7) — source: FDA, date: June 27, 2025
- [483 - NerPharMa S.r.l. - 2025-06-27](https://www.keypedia.com/records/483/nerpharma-srl/8fe3528c-de7e-4811-9cbd-81f9a82addb1) — source: FDA, date: June 27, 2025
- [483 - NerPharMa S.r.l. - 2025-06-27](https://www.keypedia.com/records/483/nerpharma-srl/85ea03e1-6a3e-4df7-9f00-3181acb33551) — source: FDA, date: June 27, 2025
- [FDA Inspection 1273996 - NerPharMa S.r.l. - 2025-06-27](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/fddf7d7f-0024-4162-b2f9-15d11c85a5e1) — source: FDA, date: June 27, 2025
- [FDA Inspection 1273996 - NerPharMa S.r.l. - 2025-06-27](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/5fe3c108-2676-47c9-ac96-2f5c3951512a) — source: FDA, date: June 27, 2025
- [FDA Inspection 1271174 - NerPharMa S.r.l. - 2024-09-13](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/9d14cc49-ac53-4eed-924c-b4dd62b15701) — source: FDA, date: September 13, 2024
- [FDA Inspection 1271174 - NerPharMa S.r.l. - 2024-09-13](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/ccbe0c79-3b35-4b3a-89b6-2d261aa3df39) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 13, 2024
- [483 - NerPharMa S.r.l. - 2024-06-19](https://www.keypedia.com/records/483/nerpharma-srl/c4a3d96a-3ef1-4a8c-a490-a578cc3de3dc) — source: FDA, date: June 19, 2024
- [483 - NerPharMa S.r.l. - 2024-06-19](https://www.keypedia.com/records/483/nerpharma-srl/665c1740-e571-418a-a5d0-7f768a20b6ee) — source: FDA, date: June 19, 2024
- [FDA Inspection 1243307 - NerPharMa S.r.l. - 2024-06-19](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/29fd3789-4bcb-4f37-aad6-30c698eb0f0e) — source: FDA, date: June 19, 2024
- [EIR - NerPharMa S.r.l. - 2023-02-20](https://www.keypedia.com/records/eir/nerpharma-srl/cd1e6bfd-e9c7-4007-88cb-e9f3d5234506) — source: FDA, date: February 20, 2023
- [FDA Inspection 1199864 - NerPharMa S.r.l. - 2023-02-20](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/8b7b8a06-c064-40dc-ae66-cc7fb620ca39) — source: FDA, date: February 20, 2023
- [FDA Inspection 1142104 - NerPharMa S.r.l. - 2020-01-17](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/1b927fab-4c56-46be-a2ee-8af8407a5369) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2020
- [FDA Inspection 1017090 - NerPharMa S.r.l. - 2017-06-01](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/571aaaf5-a629-4505-80ec-c2bebfdbc4e1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2017
- [FDA Inspection 920306 - NerPharMa S.r.l. - 2015-03-05](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/46c8e62e-d0b9-4368-86c6-868c0848f01e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 5, 2015
- [FDA Inspection 810163 - NerPharMa S.r.l. - 2012-12-12](https://www.keypedia.com/records/fda_inspections/nerpharma-srl/eff15200-0b22-46ad-9673-492045796015) — classification: No Action Indicated (NAI), source: FDA, date: December 12, 2012

## Related Companies

- [EUGIA Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/c9c73721-7ca2-4457-89c9-f1001123e141)
- [Adare Pharmaceuticals, Inc.](https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/7d8d0f1a-2012-47a6-99c8-10c2953c39af)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/05d2049f-ed44-40ae-8643-f957dc3c15f9)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf)
- [Quality Chemical Laboratories](https://www.keypedia.com/companies/quality-chemical-laboratories/57f7f773-23e6-4d97-9621-b65592c11e62)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/801e26ba-26ed-40ab-84c9-d4ee2e24e42e)
- [POINT Biopharma USA Inc.](https://www.keypedia.com/companies/point-biopharma-usa-inc/f4a8cb71-7a5c-4407-a6c8-6765aacfb8da)
- [MassBiologics South Coast](https://www.keypedia.com/companies/massbiologics-south-coast/bfed264e-18bc-497e-b0a8-29449b985350)
- [Pfizer Ireland Pharmaceuticals Unlimited Company](https://www.keypedia.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/095513de-fb4d-4c57-847c-bef3a3b235f4)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/lindsey-s-fleischman/19ba1e93-b804-487c-8c34-68dc703b0013)
- [Cynthia Jim](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)
- [investigator](https://www.keypedia.com/people/ruo-h-xu/cd7df486-187e-41a2-b424-434fa8b80648)
- [Daniel L Obstut](https://www.keypedia.com/people/daniel-l-obstut/4db3cc0f-a01b-4f68-ae35-c472ae732747)
- [Daniel B. Sweitzer](https://www.keypedia.com/people/daniel-b-sweitzer/0a03cb75-dca0-4bcc-a94f-b1db1893c240)
- [Anne P. Reid](https://www.keypedia.com/people/anne-p-reid/123cf007-29c4-4da6-83c3-228c8af415dc)